Regeneron

Regeneron takes the long-haul approach to oncology, stumbles and all
Pharma Voice
Thu, 10/10/24 - 09:52 am
Regeneron
cancer
oncology
Libtayo
FDA, after delay, clears Regeneron and Sanofi drug for COPD
BioPharma Dive
Mon, 09/30/24 - 09:25 am
Regeneron
Sanofi
Dupixent
COPD
FDA
Sanofi's Dupixent scores double COPD win in US, China
Pharmaphorum
Mon, 09/30/24 - 09:16 am
Sanofi
Regeneron
Dupixent
COPD
China
Regeneron's stock drops as it loses bid to block Amgen's Eylea biosimilar
Fierce Pharma
Tue, 09/24/24 - 11:56 am
Regeneron
Amgen
legal
biosimilars
Eylea
ESMO 2024: Regeneron’s melanoma combo therapy benefit continues beyond two years
Clinical Trials Arena
Mon, 09/16/24 - 09:46 am
ESMO
Regeneron
melanoma
clinical trials
fiablimab
Radiant Bio closes $35 million Series A funding for antibody platform
Citybiz
Wed, 09/11/24 - 11:48 am
Radiant Bio
funding
GSK
Regeneron
antibody platform
3 FDA approval dates to watch in the year’s final push
Pharma Voice
Wed, 09/11/24 - 11:39 am
FDA
Bristol Myers Squibb
KarXT
schizophrenia
Regeneron
Sanofi
Dupixent
COPD
BridgeBio
acoramidis
ATTR cardiomyopathy
Dupixent succeeds in chronic hives study, giving Sanofi, Regeneron a chance to rebound
BioPharma Dive
Wed, 09/11/24 - 11:19 am
Dupixent
chronic hives
Sanofi
Regeneron
FDA
Regeneron joins Koneksa Parkinson's digital biomarker study
Pharmaphorum
Wed, 09/4/24 - 11:22 am
Regeneron
Koneska Health
digital biomarkers
Parkinson's Disease
Merck
After FDA rejection, Regeneron gains nod in Europe for T-cell engager odronextamab
Fierce Pharma
Mon, 08/26/24 - 11:20 am
Regeneron
Europe
FDA
Ordspono
bispecifics
T-cell engager
FDA declines to approve Regeneron's blood cancer therapy
Reuters
Tue, 08/20/24 - 09:59 pm
Regeneron
FDA
linvoseltamab
Multiple Myeloma
BioNTech, Regeneron’s mRNA Cancer Vaccine Combo Clears Phase II in Melanoma
BioSpace
Tue, 07/30/24 - 11:41 am
BioNTech
Regeneron
Merck
Moderna Therapeutics
mRNA-4157/V940
melanoma
7 years after launch, Sanofi’s Dupixent is set for a megablockbuster run
Pharma Voice
Tue, 07/30/24 - 11:30 am
Sanofi
Regeneron
Dupixent
Trials to watch: Four biologics concluding pivotal COPD trials
Clinical Trials Arena
Thu, 07/25/24 - 11:36 am
COPD
biologics
clinical trials
GSK
Nucala
AstraZeneca
Fasenra
Roche
astegolimab
Sanofi
Regeneron
Dupixent
Sanofi and Regeneron's Dupixent scores in Europe as the first biologic to treat COPD
Fierce Pharma
Wed, 07/3/24 - 11:26 am
Sanofi
Regeneron
Europe
COPD
Dupixent
Dupixent repeats as top pharma ad brand, rankings largely unchanged in May
Medical Marketing and Media
Tue, 06/11/24 - 10:49 pm
pharma advertising
DTC advertising
Dupixent
Regeneron
Sanofi
Companies to watch for potential M&As in 2024
BioSpace
Wed, 06/5/24 - 11:31 am
M&A
Vertex Pharmaceuticals
Regeneron
Biogen
Moderna Therapeutics
Dupixent nears EU approval for COPD, as FDA delays
Pharmaphorum
Fri, 05/31/24 - 10:49 am
Sanofi
Regeneron
Dupixent
COPD
EMA
Europe
FDA
Who Will the Next “Big Pharma” Players Be?
BioSpace
Wed, 05/29/24 - 11:21 am
Big Pharma
Vertex Pharmaceuticals
Regeneron
Moderna Therapeutics
Zoetis
BioNTech
ASCO24: Regeneron’s Bispecific Antibody Falls Flat in Early Study
BioSpace
Fri, 05/24/24 - 11:35 am
ASCO 2024
Regeneron
clinical trials
bispecific antibodies
REGN7075
solid tumors

Pages